VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20064211 | HPV | ENSG00000147246.10 | protein_coding | HTR2C | No | No | 3358 | P28335 |
TVIS20064150 | HPV | ENSG00000147246.10 | protein_coding | HTR2C | No | No | 3358 | P28335 |
TVIS44027967 | HTLV-1 | ENSG00000147246.10 | protein_coding | HTR2C | No | No | 3358 | P28335 |
TVIS44049811 | HTLV-1 | ENSG00000147246.10 | protein_coding | HTR2C | No | No | 3358 | P28335 |
TVIS44035846 | HTLV-1 | ENSG00000147246.10 | protein_coding | HTR2C | No | No | 3358 | P28335 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | HTR2C |
---|---|
DrugBank ID | DB00458 |
Drug Name | Imipramine |
Target ID | BE0000533 |
UniProt ID | P28335 |
Regulation Type | antagonist |
PubMed IDs | 8876023; 7804391 |
Citations | Palvimaki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J: Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berl). 1996 Aug;126(3):234-40.@@Roth BL: Multiple serotonin receptors: clinical and experimental aspects. Ann Clin Psychiatry. 1994 Jun;6(2):67-78. |
Groups | Approved |
Direct Classification | Dibenzazepines |
SMILES | CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
Pathways | Imipramine Metabolism Pathway; Imipramine Action Pathway |
PharmGKB | PA449969 |
ChEMBL | CHEMBL11 |